Literature DB >> 22328081

Testosterone and interleukin-1β increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n.

Michael J Coronado1, Jessica E Brandt, Eunyong Kim, Adriana Bucek, Djahida Bedja, Eric D Abston, Jaewook Shin, Kathleen L Gabrielson, Wayne Mitzner, DeLisa Fairweather.   

Abstract

Myocarditis and dilated cardiomyopathy (DCM) are often caused by viral infections and occur more frequently in men than in women, but the reasons for the sex difference remain unclear. The aim of this study was to assess whether gene changes in the heart during coxsackievirus B3 (CVB3) myocarditis in male and female BALB/c mice predicted worse DCM in males. Although myocarditis (P = 4.2 × 10(-5)) and cardiac dilation (P = 0.008) were worse in males, there was no difference in viral replication in the heart. Fibrotic remodeling genes, such as tissue inhibitor of metalloproteinase (TIMP)-1 and serpin A 3n, were upregulated in males during myocarditis rather than during DCM. Using gonadectomy and testosterone replacement, we showed that testosterone increased cardiac TIMP-1 (P = 0.04), serpin A 3n (P = 0.007), and matrix metalloproteinase (MMP)-8 (P = 0.04) during myocarditis. Testosterone increased IL-1β levels in the heart (P = 0.02), a cytokine known to regulate cardiovascular remodeling, and IL-1β in turn increased cardiac serpin A 3n mRNA (P = 0.005). We found that 39 of 118 (33%) genes identified in acute DCM patients were significantly altered in the heart during CVB3 myocarditis in mice, including serpin A 3n (3.3-fold change, P = 0.0001). Recombinant serpin A 3n treatment induced cardiac fibrosis during CVB3 myocarditis (P = 0.0008) while decreasing MMP-3 (P = 0.04) and MMP-9 (P = 0.03) levels in the heart. Thus, serpin A 3n was identified as a gene associated with fibrotic cardiac remodeling and progression to DCM in male myocarditis patients and mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22328081      PMCID: PMC3330806          DOI: 10.1152/ajpheart.00783.2011

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  45 in total

1.  The murine orthologue of human antichymotrypsin: a structural paradigm for clade A3 serpins.

Authors:  Anita J Horvath; James A Irving; Jamie Rossjohn; Ruby H Law; Stephen P Bottomley; Noelene S Quinsey; Robert N Pike; Paul B Coughlin; James C Whisstock
Journal:  J Biol Chem       Date:  2005-09-04       Impact factor: 5.157

2.  Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production.

Authors:  Koichi Fuse; Grace Chan; Youan Liu; Patrick Gudgeon; Mansoor Husain; Manyin Chen; Wen-Chen Yeh; Shizuo Akira; Peter P Liu
Journal:  Circulation       Date:  2005-10-11       Impact factor: 29.690

Review 3.  Cardiomyopathy: an overview.

Authors:  Randell K Wexler; Terry Elton; Adam Pleister; David Feldman
Journal:  Am Fam Physician       Date:  2009-05-01       Impact factor: 3.292

4.  Demonstration of a specific androgen receptor in rat heart muscle: relationship between binding, metabolism, and tissue levels of androgens.

Authors:  M Krieg; K Smith; W Bartsch
Journal:  Endocrinology       Date:  1978-11       Impact factor: 4.736

5.  Pivotal role for alpha1-antichymotrypsin in skin repair.

Authors:  Daniel C Hoffmann; Christine Textoris; Felix Oehme; Tobias Klaassen; Andreas Goppelt; Axel Römer; Burkhard Fugmann; Jeffrey M Davidson; Sabine Werner; Thomas Krieg; Sabine A Eming
Journal:  J Biol Chem       Date:  2011-06-21       Impact factor: 5.157

6.  Transcriptomic biomarkers for the accurate diagnosis of myocarditis.

Authors:  Bettina Heidecker; Michelle M Kittleson; Edward K Kasper; Ilan S Wittstein; Hunter C Champion; Stuart D Russell; Ralph H Hruban; E Rene Rodriguez; Kenneth L Baughman; Joshua M Hare
Journal:  Circulation       Date:  2011-03-07       Impact factor: 29.690

7.  Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart.

Authors:  DeLisa Fairweather; Sylvia Frisancho-Kiss; Susy A Yusung; Masheka A Barrett; Sarah E Davis; Shannon J L Gatewood; Dolores B Njoku; Noel R Rose
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

Review 8.  Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis.

Authors:  DeLisa Fairweather; Sylvia Frisancho-Kiss; Noel R Rose
Journal:  Rev Med Virol       Date:  2005 Jan-Feb       Impact factor: 6.989

9.  The innate immune response to coxsackievirus B3 predicts progression to cardiovascular disease and heart failure in male mice.

Authors:  Jennifer A Onyimba; Michael J Coronado; Amanda E Garton; Joseph B Kim; Adriana Bucek; Djahida Bedja; Kathleen L Gabrielson; Tomas R Guilarte; DeLisa Fairweather
Journal:  Biol Sex Differ       Date:  2011-02-21       Impact factor: 5.027

10.  Microarray analysis reveals the role of matrix metalloproteinases in mouse experimental autoimmune myocarditis induced by cardiac myosin peptides.

Authors:  Qizhu Tang; Ji Huang; Haiyan Qian; Ran Xiong; Difei Shen; Hui Wu; Zhouyan Bian; Xiaohong Wei
Journal:  Cell Mol Biol Lett       Date:  2007-01-19       Impact factor: 5.787

View more
  43 in total

1.  Biomarker and more: can translocator protein 18 kDa predict recovery from brain injury and myocarditis?

Authors:  DeLisa Fairweather; Tomás R Guilarte; Leslie T Cooper
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

2.  Nano-scale treatment for a macro-scale disease: nanoparticle-delivered siRNA silences CCR2 and treats myocarditis.

Authors:  Leslie T Cooper; DeLisa Fairweather
Journal:  Eur Heart J       Date:  2014-08-24       Impact factor: 29.983

3.  Sex differences in translocator protein 18 kDa (TSPO) in the heart: implications for imaging myocardial inflammation.

Authors:  DeLisa Fairweather; Michael J Coronado; Amanda E Garton; Jennifer L Dziedzic; Adriana Bucek; Leslie T Cooper; Jessica E Brandt; Fatima S Alikhan; Haofan Wang; Christopher J Endres; Judy Choi; Martin G Pomper; Tomás R Guilarte
Journal:  J Cardiovasc Transl Res       Date:  2014-01-09       Impact factor: 4.132

Review 4.  Complexities in the relationship between infection and autoimmunity.

Authors:  Robert Root-Bernstein; DeLisa Fairweather
Journal:  Curr Allergy Asthma Rep       Date:  2014-01       Impact factor: 4.806

Review 5.  Targeting matrix metalloproteinase activity and expression for the treatment of viral myocarditis.

Authors:  Reid G Hendry; Leanne M Bilawchuk; David J Marchant
Journal:  J Cardiovasc Transl Res       Date:  2014-01-01       Impact factor: 4.132

Review 6.  Unresolved issues in theories of autoimmune disease using myocarditis as a framework.

Authors:  Robert Root-Bernstein; DeLisa Fairweather
Journal:  J Theor Biol       Date:  2014-12-04       Impact factor: 2.691

7.  TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4.

Authors:  Eric D Abston; Michael J Coronado; Adriana Bucek; Jennifer A Onyimba; Jessica E Brandt; J Augusto Frisancho; Eunyong Kim; Djahida Bedja; Yoon-kyu Sung; Andrea J Radtke; Kathleen L Gabrielson; Wayne Mitzner; DeLisa Fairweather
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-12-19       Impact factor: 3.619

Review 8.  Sex and gender differences in myocarditis and dilated cardiomyopathy.

Authors:  DeLisa Fairweather; Leslie T Cooper; Lori A Blauwet
Journal:  Curr Probl Cardiol       Date:  2013-01       Impact factor: 5.200

Review 9.  Molecular signatures and the study of gene expression profiles in inflammatory heart diseases.

Authors:  V Ruppert; B Maisch
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

10.  Autoimmune myocarditis, valvulitis, and cardiomyopathy.

Authors:  Jennifer M Myers; DeLisa Fairweather; Sally A Huber; Madeleine W Cunningham
Journal:  Curr Protoc Immunol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.